Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
100 participants
OBSERVATIONAL
2024-05-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Etiology and Prevalence of Peripheral Arterial Disease
NCT00005142
Prognostic Hemodynamic and Metabolic Profiles of Late Stage Lower Extremity Arterial Disease
NCT04143386
Mechanisms of Disability in Peripheral Arterial Disease
NCT00046592
Risk Factors of Individuals With Coronary Artery Disease
NCT00260104
Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)
NCT06122961
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will increase the understanding of the relationship between peripheral arterial disease state and biomarker expression and enable us to work towards the development of new targets for treatment.
Participants will be invited to undertake questionnaires and dedicated walking tests alongside regular blood tests to check their biomarker levels. These will be undertaken on a regular basis so the investigators can see what happens over time, such as after a surgical procedure, and see if these markers go back towards normal following intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise Therapy
Patients who are advised by their clinician to undertake exercise therapy as their treatment for peripheral arterial disease
No interventions assigned to this group
Angioplasty
Patients undergoing angioplasty for treatment of peripheral arterial disease, as advised by their clinician.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Symptomatic PAD
* ABPI \<0.8 or TBPI \<0.7
Exclusion Criteria
* Current Malignancy
* Rheumatological Condition
* Previous surgical or endovascular intervention for PAD
* ABPI \>0.8 or TBPI \>0.7
50 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Norfolk and Norwich University Hospitals NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRAS 323948
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.